Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 26Other hematologic neoplasm 16Sarcoma 1

Conditions

Lymphoma 3Dendritic Cell Sarcoma, Interdigitating 3Lymphoma, Large B-Cell, Diffuse 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 59fludarabine phosphate 39Filgrastim 36Peripheral Blood Stem Cell Transplantation 34Cyclosporine 31Radiotherapy 30Busulfan 30Mycophenolic Acid 28Antilymphocyte Serum 27Whole-Body Irradiation 25Melphalan 22Etoposide 22Methylprednisolone 20Methotrexate 20Tacrolimus 16Cord Blood Stem Cell Transplantation 16Cytarabine 12Thiotepa 10Rituximab 8Vincristine 7Granulocyte Colony-Stimulating Factor 7sargramostim 6Carboplatin 6fludarabine 5aldesleukin 5Sirolimus 5Psychiatric Rehabilitation 5Prednisone 5Leucovorin 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Mercaptopurine × Sarcoma × Clear all
NCT00018954 2012-02-20

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡